[Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients].
D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D017726:Cytomegalovirus Retinitis / Q000175:diagnosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D015828:Eye Infections, Viral / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D017245:Foscarnet / Q000008:administration & dosage / Q000627:therapeutic use; D006561:Herpes Simplex / Q000175:diagnosis / Q000188:drug therapy; D006563:Herpes Zoster Ophthalmicus / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012163:Retinal Detachment / Q000209:etiology; D015882:Retinal Necrosis Syndrome, Acute / Q000175:diagnosis / Q000188:drug therapy; D012189:Retrospective Studies; D014792:Visual Acuity; D018630:Vitreoretinopathy, Proliferative / Q000175:diagnosis
D000998:Antiviral Agents; D017245:Foscarnet; D000212:Acyclovir
Nécrose rétinienne aiguë: présentation clinique, modalités de prise en charge et pronostic à partir d'une série de 22 patients.